Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers. Issue 1 (December 2016)
- Record Type:
- Journal Article
- Title:
- Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers. Issue 1 (December 2016)
- Main Title:
- Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers
- Authors:
- Chen, Junjie
Gao, Shenmeng
Wang, Chunjing
Wang, Zhonggai
Zhang, Huxiang
Huang, Kate
Zhou, Bin
Li, Haiying
Yu, Zhijie
Wu, Jianbo
Chen, Chengshui - Abstract:
- Abstract Background The metastatic cascade is a complex and multistep process with many potential barriers. Recently, miR-193a has been reported to be a suppressive miRNA in multiple types of cancers, but its underlying anti-oncogenic activity in non-small cell lung cancers (NSCLC) is not fully elucidated. Methods The expressions of miR-193a (miR-193a-5p) in human lung cancer tissues and cell lines were detected by real-time PCR. Dual-luciferase reporter assay was used to identify the direct target of miR-193a. Cell proliferation, apoptosis, and metastasis were assessed by CCK-8, flow cytometry, and Transwell assay, respectively. Results The expression of miR-193a in lung cancer tissues was decreased comparing to adjacent non-tumor tissues due to DNA hypermethylation in lung cancer tissues. Ectopic expression of miR-193a inhibited cell proliferation, colony formation, migration, and invasion in A549 and H1299 cells. Moreover, overexpression of miR-193a partially reversed tumor growth factor-β1 (TGF-β1)-induced epithelial-to-mesenchymal transition (EMT) in NSCLC cells. Mechanistically, miR-193a reduced the expression of WT1, which negatively regulated the protein level of E-cadherin, suggesting that miR-193a might prevent EMT via modulating WT1-E-cadherin axis. Importantly, knockdown ofWT1 resembled the anti-cancer activity by miR-193a and overexpression ofWT1 partially reversed miR-193a-induced anti-cancer activity, indicating that WT1 plays an important role inAbstract Background The metastatic cascade is a complex and multistep process with many potential barriers. Recently, miR-193a has been reported to be a suppressive miRNA in multiple types of cancers, but its underlying anti-oncogenic activity in non-small cell lung cancers (NSCLC) is not fully elucidated. Methods The expressions of miR-193a (miR-193a-5p) in human lung cancer tissues and cell lines were detected by real-time PCR. Dual-luciferase reporter assay was used to identify the direct target of miR-193a. Cell proliferation, apoptosis, and metastasis were assessed by CCK-8, flow cytometry, and Transwell assay, respectively. Results The expression of miR-193a in lung cancer tissues was decreased comparing to adjacent non-tumor tissues due to DNA hypermethylation in lung cancer tissues. Ectopic expression of miR-193a inhibited cell proliferation, colony formation, migration, and invasion in A549 and H1299 cells. Moreover, overexpression of miR-193a partially reversed tumor growth factor-β1 (TGF-β1)-induced epithelial-to-mesenchymal transition (EMT) in NSCLC cells. Mechanistically, miR-193a reduced the expression of WT1, which negatively regulated the protein level of E-cadherin, suggesting that miR-193a might prevent EMT via modulating WT1-E-cadherin axis. Importantly, knockdown ofWT1 resembled the anti-cancer activity by miR-193a and overexpression ofWT1 partially reversed miR-193a-induced anti-cancer activity, indicating that WT1 plays an important role in miR-193a-induced anti-cancer activity. Finally, overexpression of miR-193a decreased the growth of tumor xenografts in mice. Conclusion Collectively, our results have revealed an important role of miR-193a-WT1-E-cadherin axis in metastasis, demonstrated an important molecular cue for EMT, and suggested a therapeutic strategy of restoring miR-193a expression in NSCLC. … (more)
- Is Part Of:
- Journal of experimental & clinical cancer research. Volume 35:Issue 1(2016)
- Journal:
- Journal of experimental & clinical cancer research
- Issue:
- Volume 35:Issue 1(2016)
- Issue Display:
- Volume 35, Issue 1 (2016)
- Year:
- 2016
- Volume:
- 35
- Issue:
- 1
- Issue Sort Value:
- 2016-0035-0001-0000
- Page Start:
- 1
- Page End:
- 15
- Publication Date:
- 2016-12
- Subjects:
- MiR-193a -- Wilm's tumor-1 -- E-cadherin -- Epithelial-to-mesenchymal transition
Cancer -- Periodicals
616.994005 - Journal URLs:
- http://rave.ohiolink.edu/ejournals/issn/17569966/ ↗
http://www.jeccr.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=618&action=archive ↗
http://link.springer.com/ ↗ - DOI:
- 10.1186/s13046-016-0450-8 ↗
- Languages:
- English
- ISSNs:
- 1756-9966
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 10959.xml